Lapinig, Anthony T.
HRN: 22 07 81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
CEFTRIAXONE 1G (VIAL)
11/13/2022
11/19/2022
IV
2g
Od
T/C Perforated Viscous Sec To GI Tb Vs Colonic New Growth
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes